About Mithra

Specialist in women’s health

Transforming options for women through innovation

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span.

Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy.

Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium.

Our Mission is to develop innovative products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span.

Today, Mithra has two complementary platforms powered by a unique CDMO facility: its innovative E4-based pipeline and its portfolio of complex therapeutics

Estetrol (E4) based projects

E4 is a naturel oestrogen produced by the human foetus during pregnancy. Mithra believes E4 has potential benefits over current estrogens in key areas including oral contraception and hormone therapy (HT).

Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond.

More

Complex therapeutics

Mithra also has extensive expertise in the development of complex and innovative products, using medical polymer technology.

Mithra has developed the contraceptive vaginal ring Myring® and Tibelia®, a therapeutic solution composed of tibolone for menopause. It focuses now on the development of a biodegradable subcutaneous implant (Zoreline®) for hormone-dependant cancers.

More

Mithra CDMO

A fully integrated ecosystem for state-of-the-art research, development & manufacturing.

Mithra CDMO is a unique facility specialized in polymeric forms, sterile injectables and hormonal tablets.

More

The name Mithra refers to the Persian god worshipped for 4,000 years and means contract, partner, ally. In Greco-Roman mythology, Mithra slew the bull and restored the reign of fertility and abundance.

The bull is itself the symbol of the city of Liège. Mithra and the values that the name conveys are embedded in the company’s DNA.